Biotechnology
Sort by: Featured Most recent Most read Most commented
77 results total, viewing 1 - 10
Amgen says ovarian cancer drug meets goal of late-stage study
Amgen Inc., the world’s largest biotechnology company by sales, said its experimental drug for recurrent ovarian cancer met a late-stage study goal, helping patients live 1.8 months longer without the disease progressing. more
Cadence breaks ground on Cranston expansion
Medical device manufacturer Cadence Inc. broke ground Wednesday on a 34,000-square-foot expansion of its Cranston facility. more
| 5/29/13
Amgen, Astellas to develop cancer, bone treatments in Japan
Amgen Inc., one of the world’s largest biotechnology companies by sales, announced a partnership with Japanese drugmaker Astellas Pharma Inc. to bring five of its experimental therapies to market in that country. more
Covidien approves separation of pharmaceuticals arm
Medical technology maker Covidien PLC’s board of directors has approved the separation of its Mallinckrodt pharmaceuticals business from the rest of Covidien, the company announced Friday. more
| 5/24/13
Mass. biotech firms look to prepare vets for openings to come
A group of human resource executives from five Massachusetts biotechnology companies gathered Tuesday to brainstorm how to better prepare military veterans for jobs in the sector, according to the Boston Business Journal. more
| 5/15/13
Jewelry designer, tennis online booking service, 3D printing marketplace win Business Plan
The 2013 edition of the Rhode Island Business Plan Competition announced its winners Tuesday afternoon at The Garage, the Greater Providence Chamber of Commerce’s exposition dedicated to identifying and inspiring high-growth companies in the Ocean State. more
| 5/14/13
Tech Collective accepts fellowship applicants
PROVIDENCE – Tech Collective is currently accepting both job postings and applicants for its 2013 fellowship program. more
5/13/13
Amgen drugs may boost survival after a nuclear attack
Amgen Inc.’s Neulasta and Neupogen and a similar blood-boosting drug from Teva Pharmaceutical Industries Ltd. may help people survive after a nuclear attack, U.S. regulators said. more
Covidien’s profits drop in 2Q as sales rise 5%
Medical technology maker Covidien Plc reported second-quarter earnings of $439 million, or 92 cents per diluted share, an 11.7 percent drop from the $497 million, or $1.02 per diluted share, it reported during the second quarter of 2012. more
| 4/26/13
Amgen tops analyst estimates as profit benefits from tax credit
Amgen Inc., which has a production facility in West Greenwich, reported first-quarter profit that beat analyst estimates because of a research tax credit. more
1 | 2 | 3 | 4 | 5 | 6 | 7 … 8 | Next »
Calendar
PBN Hosted
Events

The 2nd Annual Healthiest Employers event will recognize employers who have strong, effective Health and Wellness programs in the region. Deadline for enrollment is June 28th.
Advertisement
National
Local
Latest News